Find, compare & contact
Dexanabinol
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Dexanabinol API 112924-45-5?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Dexanabinol. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Dexanabinol
- Synonyms:
- Sinnabidol
- Cas Number:
- 112924-45-5
- DrugBank number:
- DB06444
- Unique Ingredient Identifier:
- R6VT8U5372
General Description:
Dexanabinol is a chemical compound identified by the CAS number 112924-45-5. It is known for its distinct pharmacological properties and applications.
Indications:
This drug is primarily indicated for: Investigated for use/treatment in traumatic brain injuries and neurologic disorders. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Classification:
Dexanabinol belongs to the class of organic compounds known as 2,2-dimethyl-1-benzopyrans. These are organic compounds containing a 1-benzopyran moiety that carries two methyl groups at the 2-position, classified under the direct parent group 2,2-dimethyl-1-benzopyrans. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Benzopyrans class, specifically within the 1-benzopyrans subclass.
Categories:
Dexanabinol is categorized under the following therapeutic classes: Antiemetics, Autonomic Agents, Cannabinoids and similars, Cardiovascular Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Excitatory Amino Acid Agents, Excitatory Amino Acid Antagonists, Gastrointestinal Agents, Neuroprotective Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Protective Agents, Terpenes. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Dexanabinol is a type of Antiemetics
Antiemetics are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) used to alleviate and prevent nausea and vomiting, also known as emesis. They play a vital role in managing these distressing symptoms, which can be caused by various factors such as chemotherapy, postoperative recovery, motion sickness, or gastrointestinal disorders.
Antiemetics work by targeting specific pathways in the body that trigger emesis. One common mechanism involves blocking dopamine receptors in the brain, as dopamine plays a significant role in triggering the vomiting reflex. This class of antiemetics is known as dopamine antagonists. Another mechanism involves inhibiting serotonin receptors, which are associated with nausea and vomiting. These agents, called serotonin antagonists, effectively reduce these symptoms.
In addition to dopamine and serotonin antagonists, other types of antiemetics include neurokinin-1 receptor antagonists, antihistamines, and anticholinergics. Each of these classes acts on different pathways in the body to provide relief from nausea and vomiting.
Pharmaceutical companies manufacture antiemetic APIs in accordance with strict quality control guidelines and regulations. These APIs serve as the active ingredients in various formulations, such as tablets, capsules, injections, or suppositories, designed to deliver the desired therapeutic effects.
Overall, antiemetic APIs form an essential category in the pharmaceutical industry, addressing the significant need for effective management of nausea and vomiting. Their development and availability greatly contribute to enhancing patient comfort and quality of life during various medical treatments and conditions.
